Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 21 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Vassiliki Kotoula and Keyword is Prognosis [Clear All Filters]
Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome..
Clin Breast Cancer. 19(2), 113-125.e4.
(2019). Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers..
Cancer Genomics Proteomics. 14(3), 181-195.
(2017). Protein expression patterns of cell cycle regulators in operable breast cancer..
PLoS One. 12(8), e0180489.
(2017). Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic Cancer..
Anticancer Res. 36(12), 6347-6356.
(2016).
(2016). Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial..
PLoS One. 10(5), e0124612.
(2015). Intact or broken-apart RNA: an alternative concept for ALK fusion screening in non-small cell lung cancer (NSCLC)..
Appl Immunohistochem Mol Morphol. 23(1), 60-70.
(2015). Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer..
J Natl Cancer Inst. 107(8),
(2015). Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer..
Pharmacogenomics. 16(1), 79-94.
(2015). The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping..
Breast. 23(3), 234-43.
(2014). Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer..
Clin Breast Cancer. 14(5), 330-8.
(2014). Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression..
Anticancer Res. 34(9), 4949-62.
(2014). Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer..
Oral Oncol. 50(4), 298-305.
(2014). Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer..
Anticancer Res. 34(11), 6495-503.
(2014). Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors..
Clin Exp Metastasis. 30(4), 431-9.
(2013). Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer..
PLoS One. 8(8), e70429.
(2013).
(2013).
(2013). Prognostic utility of angiogenesis and hypoxia effectors in patients with operable squamous cell cancer of the larynx..
Oral Oncol. 48(8), 709-16.
(2012). Volumetric and MGMT parameters in glioblastoma patients: survival analysis..
BMC Cancer. 12, 3.
(2012).
(2011).